pharmaceutical market – Medgate Today

VENUS REMEDIES SECURES GMP CERTIFICATION FROM MOLDOVA MINISTRY OF HEALTH FOR ANTIBIOTIC-CARBAPENEM FACILITY

January 7, 2025

6:12 am

Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026 Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has achieved a significant milestone by receiving Good Manufacturing Practices (GMP) certification from

POST TAGS:

Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel

September 22, 2023

5:50 am

News Update

admin

Oncology drugs constitute the largest proportion of the Serbian pharmaceutical market, where Venus Remedies has so far secured five marketing approvals, all in the oncology space The company is banking on the product registration from Serbia to pave the way for faster approvals for

POST TAGS:

Aditi K Chaudhary Cancer cancer medicines chemotherapy Docetaxel gemcitabine medicine Oncology pharmaceutical market President Venus Venus Remedies

VENUS REMEDIES SECURES GMP CERTIFICATION FROM MOLDOVA MINISTRY OF HEALTH FOR ANTIBIOTIC-CARBAPENEM FACILITY

POST TAGS:

Venus Remedies extends its oncology portfolio in South Eastern Europe with Serbian marketing approval for gemcitabine and docetaxel

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA